The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2015
Citation, commencement and extent1.
(1)
This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2015 and comes into force on 11th March 2015.
(2)
This Order extends to England and Wales and Scotland.
Amendment to the Misuse of Drugs (Designation) Order 20012.
(1)
(2)
In paragraph 1(a) of Part 1 of the Schedule—
(a)
“1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)”;
(b)
“4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)”.
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order 2001 by inserting a potent opoid known as MT-45 and a synthetic stimulant known as 4,4’-DMAR into Part 1 of the Schedule to that Order.
A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.